Search clinical trials for: SUVN-502
Total 3141 results
-
NestléTerminated
-
Taipei Medical UniversityCompleted
-
CinDome Pharma, Inc.Terminated
-
Statens Serum InstitutCompletedTuberculosisNetherlands
-
UPECLIN HC FM Botucatu UnespCompletedHepatitis, Viral, Human | Hepatitis C | Nutritional StatusBrazil
-
Verve Therapeutics, Inc.Not yet recruitingHeterozygous Familial Hypercholesterolemia | Premature Coronary Heart Disease
-
REGENXBIO Inc.RecruitingDuchenne Muscular DystrophyUnited States
-
J Ints BioRecruitingEGFR Mutant Advanced Non-small Cell Lung CancerKorea, Republic of, United States, Thailand
-
Cue BiopharmaRecruitingGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian CancerUnited States
-
Aegle TherapeuticsCongressionally Directed Medical Research ProgramsRecruiting
-
Chong Kun Dang PharmaceuticalSamsung Medical Center; Asan Medical Center; Seoul National University HospitalRecruiting
-
Aegle TherapeuticsNot yet recruitingDystrophic Epidermolysis Bullosa
-
ImmuneOncia Therapeutics Inc.CompletedLymphoma | Solid TumorKorea, Republic of, United States
-
Alpine Immune Sciences, Inc.TerminatedLymphoma | Advanced Solid TumorUnited States, Australia
-
UNEEG Medical A/STerminated
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Massachusetts General HospitalDana-Farber Cancer Institute; Infinity Pharmaceuticals, Inc.TerminatedLung Cancer | Stage IV Lung Cancer | Stage IIIb Lung CancerUnited States
-
Kyowa Kirin Co., Ltd.TerminatedType 2 Diabetes | Chronic Kidney DiseaseJapan
-
GenSpera, Inc.CompletedGlioblastoma MultiformeUnited States
-
KDL Inc.UnknownEnd Stage Renal Disease | HyperphosphatemiaAustralia
-
GenSpera, Inc.CompletedAdvanced Solid TumorsUnited States
-
Neothetics, IncUnknown
-
Threshold PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | High-risk Myelodysplastic Syndrome | Advanced MyelofibrosisUnited States
-
Baylor College of MedicineHarris County Hospital District; The Methodist Hospital Research InstituteWithdrawn
-
M.D. Anderson Cancer CenterReata Pharmaceuticals, Inc.CompletedSolid Tumors | Lymphoid MalignanciesUnited States
-
Xigen SACompleted
-
Infinity Pharmaceuticals, Inc.CompletedGastrointestinal Stromal Tumors | Soft Tissue SarcomasUnited States, Canada
-
MedImmune LLCCompleted
-
Parion SciencesCompleted
-
MedImmune LLCCompletedGraft Versus Host DiseaseUnited States
-
Dong-A ST Co., Ltd.CompletedOsteoarthritis, KneeKorea, Republic of
-
Immune-Onc TherapeuticsCalifornia Institute for Regenerative Medicine (CIRM)RecruitingCMML | AML With Monocytic DifferentiationUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedRheumatoid ArthritisUnited States, Denmark, Estonia, Lithuania, Netherlands, South Africa
-
Evofem Inc.Neothetics, IncTerminatedCentral Abdominal Bulging
-
Tranzyme, Inc.CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | GastroparesisUnited States, Belgium, Denmark, Finland, Germany, Norway, Poland, Sweden
-
SonaCare MedicalUnknownProstate CancerUnited States
-
Bial - Portela C S.A.Completed
-
AerasCrucell Holland BVCompletedTuberculosisSouth Africa
-
Singapore General HospitalNational Heart Centre SingaporeCompleted
-
University of California, San DiegoRecruitingComplex Regional Pain SyndromeUnited States
-
Galapagos NVCompleted
-
SensorionNot yet recruitingOtorhinolaryngologic Diseases | Ear Diseases | Hearing Disorders | Deafness | Hearing Loss, Sensorineural | Congenital Deafness | DFNB9 | OTOF Gene MutationFrance
-
Shandong TheraWisdom Biopharma Co., Ltd.RecruitingAdvanced MalignanciesChina
-
Calypso Biotech BVCompletedCeliac Disease | Eosinophilic EsophagitisNetherlands, Belgium, Finland, Germany, Norway
-
Minoryx Therapeutics, S.L.Active, not recruitingAdrenoleukodystrophySpain, United States, Hungary, France, Germany, Italy, Netherlands, United Kingdom
-
Targovax OyAgenus Inc.Withdrawn
-
InventisBio Co., LtdCompleted
-
Neurotech PharmaceuticalsCompletedMacular Telangiectasia Type 2United States, Australia, Germany
-
Neurotech PharmaceuticalsCompletedA Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol AMacular Telangiectasia Type 2United States, United Kingdom, Australia, France
-
Atriva Therapeutics GmbHTerminatedCOVID-19Germany, India, Netherlands, Poland, Romania, South Africa, Spain